Trials / Sponsors / NLS Pharmaceutics
NLS Pharmaceutics
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 Narcolepsy Type 1, Narcolepsy With Cataplexy | Phase 3 | 2024-07-15 |
| Completed | An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy Narcolepsy With Cataplexy, Narcolepsy, Narcolepsy Without Cataplexy | Phase 2 | 2021-10-26 |
| Completed | Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy Narcolepsy, Excessive Daytime Sleepiness, Cataplexy Narcolepsy | Phase 2 | 2021-09-13 |
| Completed | Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Attention Deficit Disorder With Hyperactivity | Phase 2 | 2016-08-01 |